Monthly
US$200
Billed every month
Sign in to subscribeClopidogrel Hydrogen Sulphate Tablets
As of 13 November 2026, for Clopidogrel Hydrogen Sulphate Tablets, 6 applications are listed as under review at China's CDE; 3 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 30 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders30View records ↓
Under-review filings6View records ↓
This year’s generic filers3View records ↓
NHSA approval numbers37View records ↓
API companies with A status49View records ↓
Chemical-drug catalogue
Loaded records: 30 holders; 3 in the quality-and-efficacy consistency-evaluation category, and 26 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20266055 | 2026/09/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | 国药准字H20265799 | 2026/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | Suzhou Te Rui Pharma Co., Ltd. romanized | 国药准字H20264069 | 2026/04/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Zhong Yan Pharmaceuticals Technology Co., Ltd. romanized | Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20263695 | 2026/03/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Yao Gu Yun Bio Technology Co., Ltd. romanized | Hangzhou Minsheng Pharmaceutical Co., Ltd | 国药准字H20263415 | 2026/02/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | 2026/01/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| YaoPharma Co., Ltd. | YaoPharma Co., Ltd. | 国药准字H20255204 | 2025/08/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Topfond Pharmaceutical Co., Ltd. | Topfond Pharmaceutical Co., Ltd. | 国药准字H20254305 | 2025/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | 2025/04/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20243288 | 2024/02/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234617 | 2023/12/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guo Yao Group Zhi Jun (Shenzhen) Pharmaceutical Co., Ltd. romanized | Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20234612 | 2023/12/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20233888 | 2023/06/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhongguo Taiwan Pei Li Medicines Gong Ye Co., Ltd. romanized | Zhongguo Taiwan Pei Li Medicines Gong Ye Co., Ltd. romanized | 国药准字 HC20220002 | 2022/07/07 | 75mg | Generic approved under the new chemical-drug registration classification | CDE |
| Esseti Farmaceutici S.r.l. | Laboratorios Lesvi, S.L. | 国药准字HJ20220005 | 2022/02/11 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Si Huan Pharmaceutical Co., Ltd. romanized | Beijing Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20213840 | 2021/11/03 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yang Zi Jiang Pharma Group Guangzhou Hai Rui Pharma Co., Ltd. romanized | Yang Zi Jiang Pharma Group Guangzhou Hai Rui Pharma Co., Ltd. romanized | 国药准字H20213479 | 2021/06/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang He Ze Pharmaceuticals Technology Co., Ltd. romanized | Kun Shan Long Deng Rui Di Pharmaceutical Co., Ltd. romanized | 国药准字H20213330 | 2021/05/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203701 | 2020/12/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Sheng Bo Da Wei Ye Pharmaceutical Co., Ltd. romanized | Jilin Sheng Bo Da Wei Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20203667 | 2020/12/11 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hui Zhou Xin Li Tai Pharma Co., Ltd. romanized | Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20203616 | 2020/12/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hui Zhou Xin Li Tai Pharma Co., Ltd. romanized | Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20203637 | 2020/12/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hexal AG | Sandoz Private Limited， | 国药准字HJ20200049 | 2020/11/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | 2020/11/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | 2020/10/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Yin Du Rui Di Bo Shi Laboratory Co., Ltd. romanized | H20180074 | 2020/07/07 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | 2020/06/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20120018 | 2020/05/14 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20193160 | 2019/05/29 | 75mg | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Le Pu Pharma Co., Ltd. romanized | 国药准字H20123116 | 2018/11/23 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Name not romanized | Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | 2018/11/22 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Name not romanized | Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20000542 | 2018/04/02 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20120035 | 2017/12/27 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Sanofi Clir SNC | Sanofi Winthrop Industrie | H20150256; H20150257; H20150258 | 2010/11/05 | See source | Imported originator drug | CDE |
| Sanofi Clir SNC | Sanofi Winthrop Industrie | H20171237 | 2001/01/22 | 75mg | Imported originator drug | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 37 distinct approval numbers and 32 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20213840 | See source | Category B | XB01ACL190A001010100153 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Pharmaceutical Co., Ltd. romanized | 国药准字H20234612 | See source | Category B | XB01ACL190A001010100430 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20120018 | See source | Category B | XB01ACL190A001010100553 | NHSA |
| Yang Zi Jiang Pharma Group Guangzhou Hai Rui Pharma Co., Ltd. romanized | 国药准字H20213479 | See source | Category B | XB01ACL190A001010100568 | NHSA |
| YaoPharma Co., Ltd. | 国药准字H20255204 | See source | Category B | XB01ACL190A001010101066 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001010101467 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20266055 | See source | Category B | XB01ACL190A001010101503 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20213330 | See source | Category B | XB01ACL190A001010101533 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001010101606 | NHSA |
| Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203701 | See source | Category B | XB01ACL190A001010102181 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20193160 | 75mg | Category B | XB01ACL190A001010102770 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | See source | Category B | XB01ACL190A001010103094 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20254305 | See source | Category B | XB01ACL190A001010103098 | NHSA |
| Hainan Yao Gu Yun Bio Technology Co., Ltd. romanized | 国药准字H20263415 | See source | Category B | XB01ACL190A001010104494 | NHSA |
| Sai Nuo Fei (Hangzhou) Pharmaceutical Co., Ltd. romanized | 国药准字H20056410 | See source | Category B | XB01ACL190A001010104502 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20243288 | See source | Category B | XB01ACL190A001010104565 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234617 | See source | Category B | XB01ACL190A001010104658 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001010104914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001010106988 | NHSA |
| Jilin Sheng Bo Da Wei Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20203667 | See source | Category B | XB01ACL190A001010109639 | NHSA |
| Esseti Farmaceutici S.r.l. | 国药准字HJ20220005 | See source | Category B | XB01ACL190A001010178407 | NHSA |
| HEXAL AG | 国药准字HJ20200049 | See source | Category B | XB01ACL190A001010178495 | NHSA |
| Actavis Group PTC ehf | H20140965 | 75mg | Category B | XB01ACL190A001010179040 | NHSA |
| Sanofi Clir SNC | 国药准字J20150111 | 300mg | Category B | XB01ACL190A001010180426 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001010181767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001010183344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001010183572 | NHSA |
| Pei Li Pharmaceutical Industrial Co.,Ltd. | 国药准字HC20220002 | See source | Category B | XB01ACL190A001010184303 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20213840 | See source | Category B | XB01ACL190A001010200153 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Pharmaceutical Co., Ltd. romanized | 国药准字H20234612 | See source | Category B | XB01ACL190A001010200430 | NHSA |
| Yang Zi Jiang Pharma Group Guangzhou Hai Rui Pharma Co., Ltd. romanized | 国药准字H20213479 | See source | Category B | XB01ACL190A001010200568 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001010201467 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20266055 | See source | Category B | XB01ACL190A001010201503 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20213330 | See source | Category B | XB01ACL190A001010201533 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001010201606 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | See source | Category B | XB01ACL190A001010203094 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20254305 | See source | Category B | XB01ACL190A001010203098 | NHSA |
| Hainan Yao Gu Yun Bio Technology Co., Ltd. romanized | 国药准字H20263415 | See source | Category B | XB01ACL190A001010204494 | NHSA |
| Sai Nuo Fei (Hangzhou) Pharmaceutical Co., Ltd. romanized | 国药准字H20056410 | See source | Category B | XB01ACL190A001010204502 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20243288 | See source | Category B | XB01ACL190A001010204565 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234617 | See source | Category B | XB01ACL190A001010204658 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001010204914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001010206988 | NHSA |
| Jilin Sheng Bo Da Wei Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20203667 | See source | Category B | XB01ACL190A001010209639 | NHSA |
| Dr. Reddy's Laboratories Limited | 国药准字HJ20180074 | See source | Category B | XB01ACL190A001010278377 | NHSA |
| Esseti Farmaceutici S.r.l. | 国药准字HJ20220005 | See source | Category B | XB01ACL190A001010278407 | NHSA |
| HEXAL AG | 国药准字HJ20200049 | See source | Category B | XB01ACL190A001010278495 | NHSA |
| Sanofi Winthrop Industrie | 国药准字HJ20171237 | See source | Category B | XB01ACL190A001010278814 | NHSA |
| Actavis Group PTC ehf | H20140965 | 75mg | Category B | XB01ACL190A001010279040 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001010281767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001010283344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001010283572 | NHSA |
| Pei Li Pharmaceutical Industrial Co.,Ltd. | 国药准字HC20220002 | See source | Category B | XB01ACL190A001010284303 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20213840 | See source | Category B | XB01ACL190A001010300153 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Pharmaceutical Co., Ltd. romanized | 国药准字H20234612 | See source | Category B | XB01ACL190A001010300430 | NHSA |
| Yang Zi Jiang Pharma Group Guangzhou Hai Rui Pharma Co., Ltd. romanized | 国药准字H20213479 | See source | Category B | XB01ACL190A001010300568 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001010301467 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20266055 | See source | Category B | XB01ACL190A001010301503 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20213330 | See source | Category B | XB01ACL190A001010301533 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001010301606 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20193160 | 75mg | Category B | XB01ACL190A001010302770 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | See source | Category B | XB01ACL190A001010303094 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20254305 | See source | Category B | XB01ACL190A001010303098 | NHSA |
| Hainan Yao Gu Yun Bio Technology Co., Ltd. romanized | 国药准字H20263415 | See source | Category B | XB01ACL190A001010304494 | NHSA |
| Sai Nuo Fei (Hangzhou) Pharmaceutical Co., Ltd. romanized | 国药准字H20056410 | See source | Category B | XB01ACL190A001010304502 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20243288 | See source | Category B | XB01ACL190A001010304565 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234617 | See source | Category B | XB01ACL190A001010304658 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001010304914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001010306988 | NHSA |
| Jilin Sheng Bo Da Wei Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20203667 | See source | Category B | XB01ACL190A001010309639 | NHSA |
| Dr. Reddy's Laboratories Limited | 国药准字HJ20180074 | See source | Category B | XB01ACL190A001010378377 | NHSA |
| HEXAL AG | 国药准字HJ20200049 | See source | Category B | XB01ACL190A001010378495 | NHSA |
| Sanofi Winthrop Industrie | 国药准字HJ20171237 | See source | Category B | XB01ACL190A001010378814 | NHSA |
| Actavis Group PTC ehf | H20140966 | 75mg | Category B | XB01ACL190A001010379040 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001010381767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001010383344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001010383572 | NHSA |
| Pei Li Pharmaceutical Industrial Co.,Ltd. | 国药准字HC20220002 | See source | Category B | XB01ACL190A001010384303 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20213840 | See source | Category B | XB01ACL190A001010400153 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Pharmaceutical Co., Ltd. romanized | 国药准字H20234612 | See source | Category B | XB01ACL190A001010400430 | NHSA |
| Yang Zi Jiang Pharma Group Guangzhou Hai Rui Pharma Co., Ltd. romanized | 国药准字H20213479 | See source | Category B | XB01ACL190A001010400568 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001010401467 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20266055 | See source | Category B | XB01ACL190A001010401503 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001010401606 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20193160 | 75mg | Category B | XB01ACL190A001010402770 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | See source | Category B | XB01ACL190A001010403094 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20254305 | See source | Category B | XB01ACL190A001010403098 | NHSA |
| Hainan Yao Gu Yun Bio Technology Co., Ltd. romanized | 国药准字H20263415 | See source | Category B | XB01ACL190A001010404494 | NHSA |
| Sai Nuo Fei (Hangzhou) Pharmaceutical Co., Ltd. romanized | 国药准字H20056410 | See source | Category B | XB01ACL190A001010404502 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234617 | See source | Category B | XB01ACL190A001010404658 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001010404914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001010406988 | NHSA |
| Jilin Sheng Bo Da Wei Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20203667 | See source | Category B | XB01ACL190A001010409639 | NHSA |
| Dr. Reddy's Laboratories Limited | 国药准字HJ20180074 | See source | Category B | XB01ACL190A001010478377 | NHSA |
| HEXAL AG | 国药准字HJ20200049 | See source | Category B | XB01ACL190A001010478495 | NHSA |
| Actavis Group PTC ehf | H20140966 | 75mg | Category B | XB01ACL190A001010479040 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001010481767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001010483344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001010483572 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20213840 | See source | Category B | XB01ACL190A001010500153 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001010501467 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20266055 | See source | Category B | XB01ACL190A001010501503 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001010501606 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20193160 | 75mg | Category B | XB01ACL190A001010502770 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | See source | Category B | XB01ACL190A001010503094 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20254305 | See source | Category B | XB01ACL190A001010503098 | NHSA |
| Hainan Yao Gu Yun Bio Technology Co., Ltd. romanized | 国药准字H20263415 | See source | Category B | XB01ACL190A001010504494 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234617 | See source | Category B | XB01ACL190A001010504658 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001010504914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001010506988 | NHSA |
| Jilin Sheng Bo Da Wei Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20203667 | See source | Category B | XB01ACL190A001010509639 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001010581767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001010583344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001010583572 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20213840 | See source | Category B | XB01ACL190A001010600153 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001010601467 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001010601606 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | See source | Category B | XB01ACL190A001010603094 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234617 | See source | Category B | XB01ACL190A001010604658 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001010604914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001010606988 | NHSA |
| Jilin Sheng Bo Da Wei Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20203667 | See source | Category B | XB01ACL190A001010609639 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001010681767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001010683344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001010683572 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20213840 | See source | Category B | XB01ACL190A001010700153 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001010701467 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001010701606 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | See source | Category B | XB01ACL190A001010703094 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234617 | See source | Category B | XB01ACL190A001010704658 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001010704914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001010706988 | NHSA |
| Jilin Sheng Bo Da Wei Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20203667 | See source | Category B | XB01ACL190A001010709639 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001010781767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001010783344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001010783572 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001010801606 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | See source | Category B | XB01ACL190A001010803094 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001010804914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001010806988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001010881767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001010883344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001010883572 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001010901606 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | See source | Category B | XB01ACL190A001010903094 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001010904914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001010906988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001010981767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001010983344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001010983572 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123115 | See source | Category B | XB01ACL190A001011003094 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001011004914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001011006988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001011081767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001011083344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001011083572 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001011104914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001011106988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001011181767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001011183344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001011183572 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001011204914 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001011206988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001011281767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001011283344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001011283572 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001011306988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001011381767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001011383344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001011383572 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001011406988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001011481767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001011483344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001011483572 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001011506988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001011581767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001011583344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001011583572 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001011606988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001011681767 | NHSA |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized | 国药准字H20264069 | See source | Category B | XB01ACL190A001011683344 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001011683572 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001011706988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001011781767 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001011783572 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001011806988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001011881767 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001011883572 | NHSA |
| Dong Guan Shi Yang Zhi Kang Pharmaceuticals Co., Ltd. romanized | 国药准字H20233888 | See source | Category B | XB01ACL190A001011906988 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263288 | See source | Category B | XB01ACL190A001011981767 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001011983572 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001012083572 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001012183572 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001012283572 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001012383572 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001012483572 | NHSA |
| Sichuan Lu Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253784 | See source | Category B | XB01ACL190A001012583572 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20000542 | See source | Category B | XB01ACL190A001020100553 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001020101467 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20213330 | See source | Category B | XB01ACL190A001020101533 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001020101606 | NHSA |
| Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203701 | See source | Category B | XB01ACL190A001020102181 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20193160 | 75mg | Category B | XB01ACL190A001020102770 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123116 | See source | Category B | XB01ACL190A001020103094 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001020104914 | NHSA |
| Dr. Reddy's Laboratories Limited | 国药准字HJ20180074 | See source | Category B | XB01ACL190A001020178377 | NHSA |
| Sanofi Winthrop Industrie | 国药准字HJ20171237 | See source | Category B | XB01ACL190A001020178814 | NHSA |
| Sanofi-aventis groupe | 国药准字J20180029 | 75mg | Category B | XB01ACL190A001020180426 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20000542 | See source | Category B | XB01ACL190A001020200553 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20213330 | See source | Category B | XB01ACL190A001020201533 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123116 | See source | Category B | XB01ACL190A001020203094 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001020204914 | NHSA |
| Sanofi-aventis groupe | 国药准字J20180029 | 75mg | Category B | XB01ACL190A001020280426 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20000542 | See source | Category B | XB01ACL190A001020300553 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123116 | See source | Category B | XB01ACL190A001020303094 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20000542 | See source | Category B | XB01ACL190A001020400553 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123116 | See source | Category B | XB01ACL190A001020403094 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20000542 | See source | Category B | XB01ACL190A001020500553 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123116 | See source | Category B | XB01ACL190A001020503094 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001021101606 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | See source | Category B | XB01ACL190A001021201606 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20120035 | See source | Category B | XB01ACL190A001030100553 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001030101467 | NHSA |
| Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203701 | See source | Category B | XB01ACL190A001030102181 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20193160 | 75mg | Category B | XB01ACL190A001030102770 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123116 | See source | Category B | XB01ACL190A001030103094 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001030104914 | NHSA |
| Sanofi-aventis groupe | 国药准字J20180029 | 75mg | Category B | XB01ACL190A001030180426 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20120035 | See source | Category B | XB01ACL190A001030200553 | NHSA |
| Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203701 | See source | Category B | XB01ACL190A001030202181 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20123116 | See source | Category B | XB01ACL190A001030203094 | NHSA |
| Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203701 | See source | Category B | XB01ACL190A001030302181 | NHSA |
| Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203701 | See source | Category B | XB01ACL190A001030402181 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001030801467 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001030901467 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001031001467 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001031101467 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001031201467 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001031301467 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001031401467 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001031501467 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001031601467 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20000542 | See source | Category B | XB01ACL190A001040100553 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20203534 | See source | Category B | XB01ACL190A001040101467 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001040104914 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203637 | See source | Category B | XB01ACL190A001050100553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203637 | See source | Category B | XB01ACL190A001050200553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001060100553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001060200553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001070100553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001070200553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001070300553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001070400553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001070500553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001070600553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001070700553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001070800553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001070900553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001071000553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001071100553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001071200553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001071300553 | NHSA |
| Zhejiang Jun De Bio Technology Co., Ltd. romanized | 国药准字H20203616 | See source | Category B | XB01ACL190A001080100553 | NHSA |
| Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20203609 | See source | Category B | XB01ACL190A001040204914 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 6 filings and 5 distinct first applicants.
Generic 5 · Supplement 1
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Zhejiang Nord Pharmaceutical Co., Ltd | CYHS2600231 | Generic | 2026/01/20 | Not stated by source | CDE |
| Jilin Dao Jun Pharma Co., Ltd. romanized; Suzhou Te Rui Pharma Co., Ltd. romanized | CYHS2600700 | Generic | 2026/03/23 | Not stated by source | CDE |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | CYHS2600950 | Generic | 2026/04/24 | Not stated by source | CDE |
| Zhejiang Che Tou Pharmaceutical Co., Ltd. romanized; Hangzhou Minsheng Pharmaceutical Co., Ltd | CYHS2504123 | Generic | 2025/12/02 | Not stated by source | CDE |
| Zhejiang Che Tou Pharmaceutical Co., Ltd. romanized; Hangzhou Minsheng Pharmaceutical Co., Ltd | CYHS2504122 | Generic | 2025/12/02 | Not stated by source | CDE |
| Actavis Group PTC ehf; Actavis Ltd | JYHB2050004 | Supplement | 2020/09/01 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 3 filings and 3 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Zhejiang Nord Pharmaceutical Co., Ltd | CYHS2600231 | Generic | 2026/01/20 | Not stated by source | CDE |
| Jilin Dao Jun Pharma Co., Ltd. romanized; Suzhou Te Rui Pharma Co., Ltd. romanized | CYHS2600700 | Generic | 2026/03/23 | Not stated by source | CDE |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | CYHS2600950 | Generic | 2026/04/24 | Not stated by source | CDE |
API registrations
Non-component matches: 49 companies with A status and 16 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 硫酸氢氯吡格雷 · No verified English name | IOL Chemicals and Pharmaceuticals Ltd. | Y20240000156 | A | Exact ingredient | 2026/07/14 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Jiangxi Chuan Qi Pharma Co., Ltd. romanized | Y20230001262 | I | Exact ingredient | 2024/02/08 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Xin Tian Di Pharma Co., Ltd. romanized | Y20230001350 | A | Exact ingredient | 2026/07/07 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Shijiazhuang Zhong Shuo Pharmaceutical Co., Ltd. romanized | Y20230001180 | A | Exact ingredient | 2025/08/27 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | CSPC OUYI PHARMACEUTICAL CO., LTD. | Y20230000554 | A | Exact ingredient | 2024/12/18 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Dr. Reddy’s Laboratories Ltd. | Y20220000596 | A | Exact ingredient | 2025/04/09 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Dr. Reddy's Laboratories Ltd. | Y20220000608 | A | Exact ingredient | 2025/04/29 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Arene Life Sciences Private Limited | Y20220000246 | A | Exact ingredient | 2024/10/24 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Hunan Hua Na Da Pharmaceutical Factory Shou Xing Drug Co., Ltd. romanized | Y20210000940 | A | Exact ingredient | 2023/10/19 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Shandong Li Xin Pharmaceutical Co., Ltd. romanized | Y20210001051 | A | Exact ingredient | 2025/11/07 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Tianjin Tai Pu Pharmaceutical Co., Ltd. romanized | Y20210000950 | A | Exact ingredient | 2023/05/05 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Synthimed Labs Private Limited | Y20210000629 | A | Exact ingredient | 2024/08/23 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Le Pu Pharma Co., Ltd. romanized | Y20200001051 | A | Exact ingredient | 2025/06/26 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Heilongjiang Zhen Bao Dao Pharma Co., Ltd. Ji Xi Branch romanized | Y20210000532 | A | Exact ingredient | 2024/03/29 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | AARTI DRUGS LIMITED | Y20200000957 | I | Exact ingredient | 2021/01/08 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Liao Yuan Pharma Co., Ltd. romanized | Y20200000870 | A | Exact ingredient | 2026/10/23 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Suzhou Zheng Ji Pharma Co., Ltd. romanized | Y20200000777 | A | Exact ingredient | 2026/01/23 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Jilin Hui Kang Pharmaceutical Co., Ltd. romanized | Y20200000451 | A | Exact ingredient | 2026/07/27 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Yang Zi Jiang Pharma Group Jiangsu Hai Ci Bio Pharma Co., Ltd. romanized | Y20200000100 | A | Exact ingredient | 2026/04/04 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Le Pu Pharma Co., Ltd. romanized | Y20190001006 | A | Exact ingredient | 2025/07/09 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190009777 | A | Exact ingredient | 2025/11/12 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | Y20190009735 | A | Exact ingredient | 2025/07/30 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Sichuan Qing Mu Pharmaceutical Co., Ltd. romanized | Y20190009680 | A | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Hui Zhou Xin Li Tai Pharma Co., Ltd. romanized | Y20190009462 | A | Exact ingredient | 2024/06/06 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Assia Chemical Industries Ltd. | Y20190009321 | A | Exact ingredient | 2025/07/03 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Assia Chemical Industries Ltd. | Y20190009320 | A | Exact ingredient | 2023/03/24 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | RPG Life Sciences Limited | Y20190009092 | A | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | WOCKHARDT LIMITED | Y20190008974 | A | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | WOCKHARDT LIMITED | Y20190008973 | A | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Shao Xing Jing Xin Pharma Co., Ltd. romanized | Y20190008319 | A | Exact ingredient | 2024/02/08 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Che Tou Pharmaceutical Co., Ltd. romanized | Y20190008314 | A | Exact ingredient | 2026/07/15 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Tianjin Zhong Rui Pharma Co., Ltd. romanized | Y20190008288 | A | Exact ingredient | 2024/06/15 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Suzhou Zheng Ji Pharma Co., Ltd. romanized | Y20190008280 | A | Exact ingredient | 2024/06/06 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | CSPC OUYI PHARMACEUTICAL CO., LTD. | Y20190008263 | A | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Y20190008257 | A | Exact ingredient | 2024/01/17 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Wuhan Wu Yao Pharmaceutical Co., Ltd. romanized | Y20190008247 | A | Exact ingredient | 2023/03/24 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | Y20190008241 | A | Exact ingredient | 2023/03/24 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | Y20190008231 | A | Exact ingredient | 2026/07/03 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Pu Luo Jia Yuan Pharma Co., Ltd. romanized | Y20190008217 | A | Exact ingredient | 2025/04/24 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Suzhou Li Xin Pharmaceutical Co., Ltd. romanized | Y20190008178 | A | Exact ingredient | 2026/03/03 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Chongqing Lai Mei Pharma Co., Ltd. romanized | Y20190008177 | A | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Changzhou Pharmaceutical Factory Co., Ltd. romanized | Y20190008090 | A | Exact ingredient | 2025/09/12 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Suzhou Tian Ma Jing Xi Chemical Pin Co., Ltd. romanized | Y20190008053 | A | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Lian Yun Gang Run Zhong Pharmaceutical Co., Ltd. romanized | Y20190007898 | A | Exact ingredient | 2024/03/27 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Topfond Pharmaceutical Co., Ltd. | Y20190007695 | A | Exact ingredient | 2025/07/29 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | Y20190007689 | A | Exact ingredient | 2024/11/26 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Henan Pu Rui Pharmaceutical Co., Ltd. romanized | Y20190007688 | A | Exact ingredient | 2024/12/19 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | MSN Organics Private Limited | Y20190000599 | A | Exact ingredient | 2026/09/04 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Sichuan Qing Mu Pharmaceutical Co., Ltd. romanized | Y20190000408 | A | Exact ingredient | 2025/10/30 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Aurobindo Pharma Limited | Y20190000321 | I | Exact ingredient | 2019/05/13 | CDE |
| 硫酸氢氯吡格雷（II型） · No verified English name | Suzhou Li Xin Pharmaceutical Co., Ltd. romanized | Y20180001218 | A | Exact ingredient | 2026/08/05 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | Y20180001142 | A | Exact ingredient | 2023/08/01 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Hui Zhou Xin Li Tai Pharma Co., Ltd. romanized | Y20180001667 | A | Exact ingredient | 2025/12/03 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001114 | I | Exact ingredient | 2018/09/12 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Jiangsu Pu Run Biopharmaceuticals Co., Ltd. romanized | Y20180000992 | A | Exact ingredient | 2024/11/22 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Le Pu Pharma Co., Ltd. romanized | Y20170002277 | A | Exact ingredient | 2022/09/15 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Dr. Reddy's Laboratories Limited | Y20170001482 | A | Exact ingredient | 2025/07/24 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Henan Run Hong Pharmaceutical Co., Ltd. romanized | Y20170001392 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Jiangxi Shi Mei Pharmaceutical Co., Ltd. romanized | Y20170001243 | A | Exact ingredient | 2022/10/27 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Lang Fang Gao Bo Jing Bang Pharmaceutical Co., Ltd. romanized | Y20170001224 | A | Exact ingredient | 2022/09/30 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | PRAVEEN LABORATORIES PVT. LTD. | Y20170001129 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Shandong Wei Gao Pharma Co., Ltd. romanized | Y20170001119 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Shanghai Xian Dai Ha Sen (Shang Qiu) Pharma Co., Ltd. romanized | Y20170001110 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Jin Hua Kang En Bei Biopharmaceutical Co., Ltd. romanized | Y20170000565 | A | Exact ingredient | 2024/07/31 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Shandong Luo Xin Pharma Group Co., Ltd. romanized | Y20170000395 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Jilin Sheng Bo Da Wei Ye Pharmaceutical Co., Ltd. romanized | Y20170000388 | A | Exact ingredient | 2023/08/15 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Shandong Qidu Pharmaceutical Co., Ltd. | Y20170000281 | A | Exact ingredient | 2024/02/27 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Jiu Zhou Pharma Co., Ltd. romanized | Y20170000221 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Guangdong Hong Yuan Group Pharma Co., Ltd. romanized | Y20170000218 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Jin Li Yuan Pharma Co., Ltd. romanized | Y20170000174 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Hua Run Shuang He Pharma Co., Ltd. romanized | Y20170000146 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Tianjin Hong Ri Pharma Co., Ltd. romanized | Y20170000116 | A | Exact ingredient | 2023/12/21 | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Haerbin Hua Rui Sheng Hua Pharma Co., Ltd. romanized | Y20170000111 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Jiang Bei Pharma Co., Ltd. romanized | Y20170000089 | I | Exact ingredient | — | CDE |
| 硫酸氢氯吡格雷 · No verified English name | Zhuhai Lian Bang Pharmaceutical Co., Ltd. romanized | Y20170000057 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/09/01Accepted
Chongqing Hua Sen Pharmaceutical Co., Ltd. romanized; Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized
CYHB2601666
Fact date: 2026/09/01 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Clopidogrel Hydrogen Sulphate Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy